Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Acquisitions: 2013-2023

Historic Acquisitions for BIO-TECHNE (TECH) over the last 4 years, with Dec 2023 value amounting to $3.3 million.

  • BIO-TECHNE's Acquisitions was N/A to $3.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $486.5 million, marking a year-over-year change of. This contributed to the annual value of $169.7 million for FY2024, which is 67.72% up from last year.
  • According to the latest figures from Q4 2023, BIO-TECHNE's Acquisitions is $3.3 million, which was down 98.03% from $166.4 million recorded in Q3 2023.
  • In the past 5 years, BIO-TECHNE's Acquisitions registered a high of $215.6 million during Q2 2021, and its lowest value of -$1,000 during Q1 2019.
  • Over the past 3 years, BIO-TECHNE's median Acquisitions value was $133.8 million (recorded in 2022), while the average stood at $121.6 million.
  • Examining YoY changes over the last 5 years, BIO-TECHNE's Acquisitions showed a top increase of 517.81% in 2019 and a maximum decrease of 100.00% in 2019.
  • Quarterly analysis of 4 years shows BIO-TECHNE's Acquisitions stood at $17.2 million in 2019, then reached $215.6 million in 2021, then reached $101.2 million in 2022, then surged by 64.48% to $3.3 million in 2023.
  • Its last three reported values are $3.3 million in Q4 2023, $166.4 million for Q3 2023, and $101.2 million during Q3 2022.